This Drug To Treat Double Chins Is a Perfect Fit For Botox-Maker Allergan. But Is It Too Pricey?

One thing about Allergan chief executive Brent Saunders is he doesn't waste much time. After all, he was personally involved in setting up $97 billion worth of deals last year.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news